140 related articles for article (PubMed ID: 30416686)
1. Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival.
Engqvist H; Parris TZ; Rönnerman EW; Söderberg EMV; Biermann J; Mateoiu C; Sundfeldt K; Kovács A; Karlsson P; Helou K
Oncotarget; 2018 Oct; 9(80):35162-35180. PubMed ID: 30416686
[TBL] [Abstract][Full Text] [Related]
2. Trefoil factor family proteins as potential diagnostic markers for mucinous invasive ovarian carcinoma.
Werner Rönnerman E; Pettersson D; Nemes S; Dahm-Kähler P; Kovács A; Karlsson P; Parris TZ; Helou K
Front Oncol; 2022; 12():1112152. PubMed ID: 36818673
[TBL] [Abstract][Full Text] [Related]
3. Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry.
Engqvist H; Parris TZ; Kovács A; Rönnerman EW; Sundfeldt K; Karlsson P; Helou K
Front Oncol; 2020; 10():162. PubMed ID: 32133296
[TBL] [Abstract][Full Text] [Related]
4. Morphologic Reproducibility, Genotyping, and Immunohistochemical Profiling Do Not Support a Category of Seromucinous Carcinoma of the Ovary.
Rambau PF; McIntyre JB; Taylor J; Lee S; Ogilvie T; Sienko A; Morris D; Duggan MA; McCluggage WG; Köbel M
Am J Surg Pathol; 2017 May; 41(5):685-695. PubMed ID: 28125452
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma.
Madore J; Ren F; Filali-Mouhim A; Sanchez L; Köbel M; Tonin PN; Huntsman D; Provencher DM; Mes-Masson AM
J Pathol; 2010 Feb; 220(3):392-400. PubMed ID: 19967725
[TBL] [Abstract][Full Text] [Related]
6. Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML
Gynecol Oncol; 2018 Sep; 150(3):527-533. PubMed ID: 30054102
[TBL] [Abstract][Full Text] [Related]
7. Analysis of gene expression in early-stage ovarian cancer.
Marchini S; Mariani P; Chiorino G; Marrazzo E; Bonomi R; Fruscio R; Clivio L; Garbi A; Torri V; Cinquini M; Dell'Anna T; Apolone G; Broggini M; D'Incalci M
Clin Cancer Res; 2008 Dec; 14(23):7850-60. PubMed ID: 19047114
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets.
Wu Q; Lothe RA; Ahlquist T; Silins I; Tropé CG; Micci F; Nesland JM; Suo Z; Lind GE
Mol Cancer; 2007 Jul; 6():45. PubMed ID: 17623056
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma.
Parris TZ; Rönnerman EW; Engqvist H; Biermann J; Truvé K; Nemes S; Forssell-Aronsson E; Solinas G; Kovács A; Karlsson P; Helou K
Oncotarget; 2018 May; 9(35):24140-24154. PubMed ID: 29844878
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of Ovarian Carcinoma Histotype Based on Limited Sampling: A Prospective Study Comparing Cytology, Frozen Section, and Core Biopsies to Full Pathologic Examination.
Hoang LN; Zachara S; Soma A; Köbel M; Lee CH; McAlpine JN; Huntsman D; Thomson T; van Niekerk D; Singh N; Gilks CB
Int J Gynecol Pathol; 2015 Nov; 34(6):517-27. PubMed ID: 26107565
[TBL] [Abstract][Full Text] [Related]
11. Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.
Mori S; Gotoh O; Kiyotani K; Low SK
J Hum Genet; 2021 Sep; 66(9):853-868. PubMed ID: 34092788
[TBL] [Abstract][Full Text] [Related]
12. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
13. GAB2 and GAB3 are expressed in a tumor stage-, grade- and histotype-dependent manner and are associated with shorter progression-free survival in ovarian cancer.
Berkel C; Cacan E
J Cell Commun Signal; 2021 Mar; 15(1):57-70. PubMed ID: 32888136
[TBL] [Abstract][Full Text] [Related]
14. Molecular insights into the classification of high-grade endometrial carcinoma.
Hussein YR; Soslow RA
Pathology; 2018 Feb; 50(2):151-161. PubMed ID: 29246451
[TBL] [Abstract][Full Text] [Related]
15. Histologic type, organ of origin, and Wnt pathway status: effect on gene expression in ovarian and uterine carcinomas.
Shedden KA; Kshirsagar MP; Schwartz DR; Wu R; Yu H; Misek DE; Hanash S; Katabuchi H; Ellenson LH; Fearon ER; Cho KR
Clin Cancer Res; 2005 Mar; 11(6):2123-31. PubMed ID: 15788657
[TBL] [Abstract][Full Text] [Related]
16. Genetic classification of ovarian carcinoma based on microsatellite analysis: relationship to clinicopathological features and patient survival.
Huan Z; Nakayama K; Nakayama N; Ishibashi M; Yeasmin S; Katagiri A; Purwana IN; Iida K; Maruyama R; Fukumoto M; Miyazaki K
Oncol Rep; 2008 Mar; 19(3):775-81. PubMed ID: 18288415
[TBL] [Abstract][Full Text] [Related]
17. Low-Stage High-Grade Serous Ovarian Carcinomas: Support for an Extraovarian Origin.
Morency E; Leitao MM; Soslow RA
Int J Gynecol Pathol; 2016 May; 35(3):222-9. PubMed ID: 26630225
[TBL] [Abstract][Full Text] [Related]
18. Current status on microRNAs as biomarkers for ovarian cancer.
Prahm KP; Novotny GW; Høgdall C; Høgdall E
APMIS; 2016 May; 124(5):337-55. PubMed ID: 26809719
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of transcriptome reveals let-7b as an unfavorable prognostic biomarker and predicts molecular and clinical subclasses in high-grade serous ovarian carcinoma.
Tang Z; Ow GS; Thiery JP; Ivshina AV; Kuznetsov VA
Int J Cancer; 2014 Jan; 134(2):306-18. PubMed ID: 23825028
[TBL] [Abstract][Full Text] [Related]
20. The histomorphology of Lynch syndrome-associated ovarian carcinomas: toward a subtype-specific screening strategy.
Chui MH; Ryan P; Radigan J; Ferguson SE; Pollett A; Aronson M; Semotiuk K; Holter S; Sy K; Kwon JS; Soma A; Singh N; Gallinger S; Shaw P; Arseneau J; Foulkes WD; Gilks CB; Clarke BA
Am J Surg Pathol; 2014 Sep; 38(9):1173-81. PubMed ID: 25025451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
